Trial Profile
A real life study analysing Ipilimumabin in Irish patients in the Oncology Drug Management System and estimated mean overall survival
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2016
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 08 Nov 2016 New trial record